Anti‑VEGF treatment suppresses remodeling factors and restores epithelial barrier function through the E‑cadherin/β‑catenin signaling axis in experimental asthma models


Creative Commons License

Türkeli A.

Experimental And Therapeutic Medicine, ss.1-9, 2021 (SCI-Expanded)